MedPath

Effectiveness of Pilates Exercises in the Treatment of Dysmenorrhea: A Randomized Controlled Trial

Not Applicable
Completed
Conditions
Dysmenorrhea
Registration Number
NCT06774521
Lead Sponsor
Uskudar University
Brief Summary

The aim of this study is to investigate the effectiveness of Pilates exercises in the treatment of dysmenorrhea and to contribute to the literature and information on this subject.

Detailed Description

The study was planned as a randomized controlled study. The study will be conducted at the Fizyorapt physiotherapy and exercise consultancy center. It will be divided into 2 main groups as those between the ages of 18-50, those with a menstrual period of 3-9 days, those with menstrual pain complaints, and those who cooperate in completing the assessment scales. Participants will be asked to continue the given exercises for 6 weeks, 2 days a week and 45 minutes. People with psychological and physical disabilities will not be included in regular exercise. A personal information form will be prepared by the researcher in order to collect data on the sociodemographic characteristics of the participants. Visual analog scale (VAS) will be used to measure pain intensity and pain relief, Beck depression scale to determine depression symptoms, and menstruation symptom scale to evaluate menstrual pain and symptoms. These surveys will be repeated before and at the end of the study. The data to be obtained will be evaluated using the SPSS24 package program.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
45
Inclusion Criteria
  • Female individuals between the ages of 18-50
  • Those with a menstrual period of 3-9 days
  • Having menstrual pain complaints in most of their menstrual cycles
  • Cooperating in completing the assessment scales
Exclusion Criteria
  • Having a history of abdominal surgery

  • Having an active infection

  • Having knee pain

    -. Using medication

  • Participants with any pathology that prevents exercise will not be included in the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Visual Analogue Scale14 weeks

Participants were included in the "healthy" category when they marked the 0-1 range of the scale, and were included in the "Menstruation pain" category when they marked the 1.1-10 range. They were divided into 3 groups according to pain severity. 1.1-3: Mild pain, 3.1-7: Moderate pain, 7.1-10: Severe pain.

Menstruation Symptom Scale14 weeks

It is a 5-point Likert-type scale and consists of three sub-parameters: 'negative effects/somatic effects', 'menstrual pain' and 'coping methods', and 22 items. The person is asked to give a score between '1' never and '5' always for the symptoms they experience related to menstruation. The Menstruation Symptom Scale (MSS) score is calculated by taking the total score average. An increase in the mean score indicates an increase in the severity of menstrual symptoms.

Fatigue Severity Scale14 weeks

It consists of 9 questions. Each question is scored between 1 and 7. Statements Regarding Scoring 1. I strongly disagree 3. I tend to disagree 5. I tend to agree 2. I disagree 4. I am undecided 6. I agree 7. I strongly agree. ) the score of the answers given to the question is added and divided by 9. If the result is less than 2.8, it is evaluated as "no fatigue". If the result is greater than 6.1, it is considered as "chronic fatigue syndrome

Pittsburgh Sleep Quality Index14 weeks

It was developed by Buysse et al. (1989) (34). The scale is a safe and consistent questionnaire that evaluates the amount of sleep, sleep quality, presence and severity of sleep disorders in individuals in the last month. It was adapted into Turkish by Ağargün et al. (1996) (35). There are seven components in Pittsburg Sleep Quality Index. These components are subjective sleep quality (component 1), sleep latency (component 2), sleep duration (component 3), habitual sleep efficiency (component 4), sleep disturbance (component 5), sleep medication use (component 6) and daytime dysfunction. (component 7). The evaluation score of each item is between 0-3. The total score obtained varies between 0-21. The higher the score, the worse the sleep quality.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Fizyorapt

🇹🇷

Istanbul, Turkey

© Copyright 2025. All Rights Reserved by MedPath